Glutathione Injection
US$ 20.12
bpc-157 human case report clinical trial Peptide Therapy for Pain Management and Healing Columbia Undergraduate Science Journal
Description
Advanced arthritis, complete tendon tears, labral damage, disc herniations, and bone spurs generally show minimal response to peptide therapy
doi:10.1177/2040622320936023
Peptides theoretically promote tissue repair rather than just symptom management
Week 4 (end of standard cycle)
In the early 2000s, the company held two early-stage trials to see if BPC-157 could help treat ulcerative colitis
